U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054060) titled 'Endarterectomy Versus Stenting in Patients With Symptomatic Severe Carotid Stenosis - 2' on May 13.
Brief Summary: Carotid stenosis caused by atherosclerosis is a significant risk factor for ischemic stroke, accounting for up to 15% of all strokes and transient ischemic attacks. Randomized clinical trials (RCTs) have demonstrated the benefits of carotid endarterectomy (CEA) in reducing stroke risk in patients with severe symptomatic carotid stenosis. Carotid artery stenting (CAS) has been developed as an alternative to CEA, offering several potential advantages, such as avoiding local surgical complications. However, unlike CEA, CAS ...